Respiratory disease treatment

Details Respiratory disease treatment Respiratory disease treatment

A - Human Necessities

61

K

A61K 9/00 (2006.01) A61K 31/427 (2006.01) A61P 11/00 (2006.01)

Patent

CA 2733440

There is provided a pharmaceutical composition that is adapted for pulmonary administration by inhalation, which composition comprises a glitazone, such as pioglitazone or rosiglitazone, and one or more pharmaceutically acceptable carriers and/or excipients, and wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. There is also provided a use and a kit.

L'invention porte sur une composition pharmaceutique qui est conçue pour une administration pulmonaire par inhalation; cette composition comporte un glitazone, tel que le pioglitazone ou le rosiglitazone, et un ou plusieurs supports de qualité pharmaceutique et/ou excipients, la teneur en glitazone de la composition consistant en au moins 95 % en poids de l'énantiomère R5 et moins de 5 % en poids de l'énantiomère 5S. L'invention porte également sur une utilisation et sur un kit.

Affiliated with

Also associated with

Rating

Respiratory disease treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Respiratory disease treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Respiratory disease treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1914231